Search Results
AWS re:Invent 2019 – Daphne Koller of insitro Talks About Using AWS to Transform Drug Development
Daphne Koller, CEO and Founder of insitro, speaks at the 2019 Amazon re:MARS conference.
E1089 Next Unicorns E11: insitro CEO Daphne Koller is optimizing drug discovery via machine learning
Machine Learning: New Approach to Drug Discovery - Daphne Koller, Founder, Insitro
Transforming Drug Discovery using Digital Biology Daphne Koller
WSAI Americas 2019 - insitro, Daphne Koller, Founder and CEO
Rethinking Drug Discovery Using Machine Learning
Machine Learning: A New Approach to Drug Discovery | Daphne Koller | WiDS 2020
AWS re:Invent 2019 - Peter DeSantis による Monday Night Live | AWS (日本語字幕)
AWS re:Invent 2019 - Keynote with Andy Jassy
Daphne Koller: How machine learning is transforming drug discovery
Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332
